Two cases of eczematous eruptions caused by everolimus

Abstract Objective Everolimus, an inhibitor of the mammalian target of rapamycin, has been used in the treatment of several types of tumor. Erythematous maculopapular and acneiform rashes are the major dermatological adverse events associated with everolimus therapy, but we encountered two cases of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Minako Habu (Autor), Mikiko Tohyama (Autor), Koji Sayama (Autor)
Formato: Libro
Publicado: Frontiers Media S.A., 2019-10-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible